F6777

Flecainide acetate salt

≥98% (TLC), powder, sodium channel blocker

• 동의어(들): N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt
• 실험식(Hill 표기법): C₁₇H₂₀F₆N₂O₃ · C₂H₄O₂
• CAS Number: 54143-56-5
• Molecular Weight: 474.39
• EC Number: 258-997-5
• MDL number: MFCD00214290
• UNSPSC 코드: 12352200
• PubChem Substance ID: 24278440
• NACRES: NA.77

속성

• Product Name: Flecainide acetate salt,
• Quality Level: 200
• 주관자: Medicis
• 저장 온도: 2-8°C
• SMILES string: CC(O)=O.FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2
• InChI: 1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)
• InChI key: RKXNZRPQSOPPRN-UHFFFAOYSA-N
• 유전자 정보: human ... SCN5A(6331)

설명

생화학적/생리학적 작용

Class IC antiarrhythmic agent; sodium channel blocker

특징 및 장점

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Medicis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• 픽토그램: GHS08,GHS07
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H335,H360FD
• 예방조치 성명서: P202 - P261 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable